A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 146.28
GOOG 965.59
MSFT 71.21
BAC 22.82
FB 155.07

Recently Added

TIF 91.79
SNAP 17.54
UAA 21.20
LSTR 84.25
UDOW 121.32

Gaining Speed

AAPL 146.28
GOOG 965.59
MSFT 71.21
BAC 22.82
FB 155.07

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!